Station 41 Venture Studio provides technology programs with the corporate structure and resources to advance further via non-dilutive and equity funding. The Venture Studio was launched by SR in 2022, which implemented a program prioritization rubric using commercial, regulatory, and scientific diligence processes aligned to venture capital standards.

The Venture Studio will launch three cohorts annually, aligned to NIH non-dilutive funding deadlines. In addition to seeding and prioritizing further development of core technologies, the Venture Studio Director and team will launch a business development and marketing function for the spinout entity, including creation of a corporate brand, website, and relevant marketing assets.